Mukka Proteins Limited has extended the deadline for its strategic investment in Aqua Marine to January 31, 2027. The company cited procedural issues as the reason for the delay in executing the acquisition of a 51% stake.

The original timeline for completing the transaction was September 30, 2026. This extension follows an initial announcement made on June 12, 2026, regarding the planned capital contribution. The total value of the investment is capped at ₹15 crore.

Acquisition details

The following table outlines the key parameters of the delayed acquisition:

Regulatory compliance and next steps

Mukka Proteins filed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that all necessary steps are being taken to address the delays. Management stated that the acquisition through capital contribution will be completed in due course.

The transaction involves acquiring a majority stake in Aqua Marine, a partnership firm, through one or more tranches of capital contribution. The revised schedule provides additional time to resolve the identified procedural hurdles before finalizing the deal.

Mukka Proteins Limited has rescheduled its virtual analyst and institutional investor meeting with Suraag Capital to Tuesday, September 29, 2026. The interaction, originally slated for Monday, September 28, 2026, remains a one-on-one session allowing direct engagement between the company's management and the investment firm.

The company filed this intimation with the National Stock Exchange of India and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure ensures transparency regarding the company's participation in investor conferences and meetings, noting that the schedule may undergo changes at the discretion of the analyst, institutional investor, or the company.

Meeting details and compliance

The updated schedule for the rescheduled meeting is as follows:

Mukka Proteins stated that no unpublished price sensitive information pertaining to the company will be disclosed or shared during any of its meetings with analysts or institutional investors. The company emphasized that this rescheduling does not alter the nature of the engagement, which continues to be a direct dialogue format.

Investor resources

Stakeholders can access the latest investor presentation on the company's official website. The document provides updated information on the company's operations as a manufacturer and exporter of steam dried fish meal, fish oil, and fish soluble paste.